IVCC congratulates BASF on the news of the prequalification of Sylando® 240 SC by the World Health Organization (WHO).  This is a welcome new mode of action in the indoor residual spraying (IRS) toolbox. Sylando® 240 SC represents a significant breakthrough, providing a new tool to allow programme managers to rotate between chemistries and be better equipped to manage resistance.

Similar to BASF’s Interceptor® G2 dual insecticide treated nets (ITNs), Sylando® 240 SC formulation contains chlorfenapyr; a potent insecticide for combating mosquitoes for public health.

IVCC supported BASF by providing scientific advice, laboratory support, and supporting rigorous field trials to prove Sylando® 240 SC’s efficacy.

Justin McBeath, Chief Executive Officer at IVCC, said: “Mosquito resistance to current insecticides has been one of the principal reasons for the recent stalling in the gains made since the turn of the century, so we desperately need effective chemistry with modes of action new to public health to combat these resistant mosquitoes, and enable rotation with other products. News that Sylando® 240 SC has recently obtained a WHO PQ listing is therefore very welcome and will prove to be a very valuable part of the vector control toolbox.”

The new BASF Public Health product will be available to protect people from vector-borne diseases such as malaria.

For further information on the WHO Prequalification of Sylando® 240 SC visit: https://extranet.who.int/prequal/vector-control-products/sylando-240-sc

As resistance to pyrethroid insecticides continues to spread and decisions about how to deploy specific interventions are becoming increasingly complex, questions remain about the best methods for layering new tools to maximize program impact. Join PATH on June 25th at 9AM EDT via Zoom (details below) as we interview experts on the effects of layering IRS and LLINs from the Unitaid-funded NgenIRS Project.

Our experts:

• Sergi Alonso, PhD, ISGlobal in conversation with Rose Zulliger, PhD, US President’s Malaria Initiative/Center for Disease Control, Division of Parasitic Diseases and Malaria. Discussion topic: Evidence from a cluster-randomized control trial in Mopeia, Mozambique on the direct and indirect costs of IRS with non-pyrethroid insecticide in a high burden area of Mozambique with high coverage of LLINs.

• Ellie Sherrard-Smith, PhD, Imperial College in conversation with Helen Jamet, PhD, Bill & Melinda Gates Foundation. Discussion topic: Using models to make product layering decisions.

• Joshua Yukich, PhD, Tulane University in conversation with Alexandra Cameron, PhD, Unitaid. Discussion topic: Meta-analysis of the cost and cost-effectiveness of 3GIRS products in Ghana, Mali, Mozambique, and Uganda in areas with access to LLINs.

Please register at the link below and submit any questions you have for the experts in advance. Looking forward to seeing you!